Fecal microbiota transplantation: Past, present and future perspectives

Minerva Gastroenterologica e Dietologica

Volumn 63, Issue 4, 2017, Pages 420-430

  Bibbò, Stefano ^a   Ianiro, Gianluca ^a   Gasbarrini, Antonio ^a   Cammarota, Giovanni ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Clostridium difficile; Fecal microbiota transplantation; Gastrointestinal microbiome; Inflammatory bowel diseases; Irritable bowel syndrome

Indexed keywords

VANCOMYCIN;

BACTERIAL GROWTH; CLINICAL DISEASE ACTIVITY INDEX; CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; FECAL MICROBIOTA TRANSPLANTATION; FECES ANALYSIS; GASTROSCOPY; GRAFT VERSUS HOST REACTION; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; IRRITABLE COLON; METABOLIC DISORDER; MULTIDRUG RESISTANCE; NEUROLOGIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; CLOSTRIDIUM INFECTION; PROCEDURES; TREATMENT OUTCOME; TRENDS;

CLOSTRIDIUM INFECTIONS; FECAL MICROBIOTA TRANSPLANTATION; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATORY BOWEL DISEASES; IRRITABLE BOWEL SYNDROME; METABOLIC DISEASES; TREATMENT OUTCOME;

EID: 85030455845     PISSN: 1121421X     EISSN: 18271642     Source Type: Journal    
DOI: 10.23736/S1121-421X.17.02374-1     Document Type: Review

References (79)

1. Rajilic-Stojanovic M, de Vos WM. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev 2014;38: 996-1047.
2. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature 2007;449: 804-10.
3. Rajilic-Stojanovic M. Function of the microbiota. Best Pract Res Clin Gastroenterol 2013;27: 5-16.
4. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010;90: 859-904.
5. Viggiano D, Ianiro G, Vanella G, Bibbo S, Bruno G, Simeone G, et al. Gut barrier in health and disease: Focus on childhood. Eur Rev Med Pharmacol Sci 2015;19: 1077-85.
6. Simren M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, et al. Intestinal microbiota in functional bowel disorders: A Rome foundation report. Gut 2013;62: 159-76.
7. Bibbo S, Lopetuso LR, Ianiro G, Di Rienzo T, Gasbarrini A, Cammarota G. Role of microbiota and innate immunity in recurrent Clostridium difficile infection. J Immunol Res 2014;2014: 462740.
8. Cammarota G, Ianiro G, Cianci R, Bibbo S, Gasbarrini A, Curro D. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy. Pharmacol Ther 2015;149: 191-212.
9. Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases. Gastroenterology 2014;146: 1513-24.
10. Abreu MT, Peek RM Jr. Gastrointestinal malignancy and the microbiome. Gastroenterology 2014;146: 1534-46.e3.
11. Nieuwdorp M, Gilijamse PW, Pai N, Kaplan LM. Role of the microbiome in energy regulation and metabolism. Gastroenterology 2014;146: 1525-33.
12. Bibbo S, Dore MP, Pes GM, Delitala G, Delitala AP. Is there a role for gut microbiota in type 1 diabetes pathogenesis? Ann Med 2017;49: 11-22.
13. Prince BT, Mandel MJ, Nadeau K, Singh AM. Gut Microbiome and the Development of Food Allergy and Allergic Disease. Pediatr Clin North Am 2015;62: 1479-92.
14. Li Q, Zhou JM. The microbiota-gut-brain axis and its potential therapeutic role in autism spectrum disorder. Neuroscience 2016;324: 131-9.
15. Cammarota G, Ianiro G, Bibbo S, Gasbarrini A. Gut microbiota modulation: Probiotics, antibiotics or fecal microbiota transplantation? Intern Emerg Med 2014;9: 365-73.
16. Ianiro G, Bibbo S, Gasbarrini A, Cammarota G. Therapeutic modulation of gut microbiota: Current clinical applications and future perspectives. Curr Drug Targets 2014;15: 762-70.
17. Cammarota G, Ianiro G, Gasbarrini A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: A systematic review. J Clin Gastroenterol 2014;48: 693-702.
18. Borody TJ. "Flora Power"-fecal bacteria cure chronic C. difficile diarrhea. Am J Gastroenterol 2000;95: 3028-9.
19. Cammarota G, Ianiro G, Bibbo S, Gasbarrini A. Fecal microbiota transplantation: A new old kid on the block for the management of gut microbiota-related disease. J Clin Gastroenterol 2014;48 Suppl 1: S80-4.
20. Zhang F, Luo W, Shi Y, Fan Z, Ji G. Should we standardize the 1,700-year-old fecal microbiota transplantation? Am J Gastroenterol 2012;107: 1755; author reply p -6.
21. Borody TJ, Warren EF, Leis SM, Surace R, Ashman O, Siarakas S. Bacteriotherapy using fecal flora: Toying with human motions. J Clin Gastroenterol 2004;38: 475-83.
22. Gasbarrini G, Bonvicini F, Gramenzi A. Probiotics History. J Clin Gastroenterol 2016;50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015: S116-S9.
23. Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal en ema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958;44: 854-9.
24. Schwan A, Sjolin S, Trottestam U, Aronsson B. Relapsing clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet 1983;2: 845.
25. Cammarota G, Ianiro G, Tilg H, Rajilic-Stojanovic M, Kump P, Satokari R, et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut 2017;66: 569-80.
26. Owyang C, Wu GD. The gut microbiome in health and disease. Gastroenterology 2014;146: 1433-6.
27. Kelly CR, Kahn S, Kashyap P, Laine L, Rubin D, Atreja A, et al. Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook. Gastroenterology 2015;149: 223-37.
28. Song Y, Garg S, Girotra M, Maddox C, von Rosenvinge EC, Dutta A, et al. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. PLoS One 2013;8: E81330.
29. Li SS, Zhu A, Benes V, Costea PI, Hercog R, Hildebrand F, et al. Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 2016;352: 586-9.
30. Ott SJ, Waetzig GH, Rehman A, Moltzau-Anderson J, Bharti R, Grasis JA, et al. Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection. Gastroenterology 2017;152: 799-811.e7.
31. Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: Systematic review and meta-analysis. Am J Gastroenterol 2013;108: 500-8.
32. Kelly CP, Lamont JT. Clostridium difficile-more difficult than ever. N Engl J Med 2008;359: 1932-40.
33. Kelly CP. Can we identify patients at high risk of recurrent Clostridium difficile infection? Clin Microbiol Infect 2012;18 Suppl 6: 21-7.
34. Lo Vecchio A, Zacur GM. Clostridium difficile infection: An update on epidemiology, risk factors, and therapeutic options. Curr Opin Gastroenterol 2012;28: 1-9.
35. Chapman BC, Moore HB, Overbey DM, Morton AP, Harnke B, Gerich ME, et al. Fecal microbiota transplant in patients with Clostridium difficile infection: A systematic review. J Trauma Acute Care Surg 2016;81: 756-64.
36. Drekonja D, Reich J, Gezahegn S, Greer N, Shaukat A, Macdonald R, et al. Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review. Ann Intern Med 2015;162: 630-8.
37. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013;368: 407-15.
38. Cammarota G, Masucci L, Ianiro G, Bibbo S, Dinoi G, Costamagna G, et al. Randomised clinical trial: Faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther 2015;41: 835-43.
39. Lee CH, Steiner T, Petrof EO, Smieja M, Roscoe D, Nematallah A, et al. Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial. JAMA 2016;315: 142-9.
40. Youngster I, Sauk J, Pindar C, Wilson RG, Kaplan JL, Smith MB, et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: A randomized, open-label, controlled pilot study. Clin Infect Dis 2014;58: 1515-22.
41. Youngster I, Mahabamunuge J, Systrom HK, Sauk J, Khalili H, Levin J, et al. Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection. BMC Med 2016;14: 134.
42. Furuya-Kanamori L, Doi SA, Paterson DL, Helms SK, Yakob L, McKenzie SJ, et al. Upper Versus Lower Gastrointestinal Delivery for Transplantation of Fecal Microbiota in Recurrent or Refractory Clostridium difficile Infection: A Collaborative Analysis of Individual Patient Data From 14 Studies. J Clin Gastroenterol 2017;51: 145-50.
43. Fischer M, Kao D, Mehta SR, Martin T, Dimitry J, Keshteli AH, et al. Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study. Am J Gastroenterol 2016;111: 1024-31.
44. Ianiro G, Valerio L, Masucci L, Pecere S, Bibbo S, Quaranta G, et al. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: Results from a threeyear, single-centre cohort study. Clin Microbiol Infect 2017;23: 337.e1-337.e3.
45. Cammarota G, Ianiro G, Magalini S, Gasbarrini A, Gui D. Decrease in Surgery for Clostridium difficile Infection After Starting a Program to Transplant Fecal Microbiota. Ann Intern Med 2015;163: 487-8.
46. Debast SB, Bauer MP, Kuijper EJ, European Society of Clinical M, Infectious D. European Society of Clinical Microbiology and Infectious Diseases: Update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 2014;20 Suppl 2: 1-26.
47. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013;108: 478-98; quiz 99.
48. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134: 577-94.
49. Ianiro G, Bibbo S, Scaldaferri F, Gasbarrini A, Cammarota G. Fecal microbiota transplantation in inflammatory bowel disease: Beyond the excitement. Medicine (Baltimore) 2014;93: E97.
50. Colman RJ, Rubin DT. Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis. J Crohns Colitis 2014;8: 1569-81.
51. Moayyedi P, Surette MG, Kim PT, Libertucci J, Wolfe M, Onischi C, et al. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology 2015;149: 102-9.e6.
52. Rossen NG, Fuentes S, van der Spek MJ, Tijssen JG, Hartman JH, Duflou A, et al. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis. Gastroenterology 2015;149: 110-8.e4.
53. Scaldaferri F, Pecere S, Petito V, Zambrano D, Fiore L, Lopetuso LR, et al. Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis. Transplant Proc 2016;48: 402-7.
54. Vermeire S, Joossens M, Verbeke K, Wang J, Machiels K, Sabino J, et al. Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease. J Crohns Colitis 2016;10: 387-94.
55. Wei Y, Zhu W, Gong J, Guo D, Gu L, Li N, et al. Fecal Microbiota Transplantation Improves the Quality of Life in Patients with Inflammatory Bowel Disease. Gastroenterol Res Pract 2015;2015: 517597.
56. Mayer EA, Savidge T, Shulman RJ. Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology 2014;146: 1500-12.
57. Bennet SM, Ohman L, Simren M. Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver 2015;9: 318-31.
58. Ringel Y, Maharshak N. Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2013;305: G529-41.
59. Curro D, Ianiro G, Pecere S, Bibbo S, Cammarota G. Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders. Br J Pharmacol 2016.
60. Pinn DM, Aroniadis OC, Brandt LJ. Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)? Neurogastroenterol Motil 2015;27: 19-29.
61. Borody TJ, George L, Andrews P, Brandl S, Noonan S, Cole P, et al. Bowel-flora alteration: A potential cure for inflammatory bowel disease and irritable bowel syndrome? Med J Aust 1989;150: 604.
62. Pinn DM, Aroniadis OC, Brandt LJ. Is fecal microbiota transplantation the answer for irritable bowel syndrome? A single-center experience. Am J Gastroenterol 2014;109: 1831-2.
63. Andrews PJ, Borody TJ. "Putting back the bugs": Bacterial treatment relieves chronic constipation and symptoms of irritable bowel syndrome. Med J Aust 1993;159: 633-4.
64. Ge X, Tian H, Ding C, Gu L, Wei Y, Gong J, et al. Fecal Microbiota Transplantation in Combination with Soluble Dietary Fiber for Treatment of Slow Transit Constipation: A Pilot Study. Arch Med Res 2016;47: 236-42.
65. Borody TJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: Indications, methods, evidence, and future directions. Curr Gastroenterol Rep 2013;15: 337.
66. Evrensel A, Ceylan ME. Fecal Microbiota Transplantation and Its Usage in Neuropsychiatric Disorders. Clin Psychopharmacol Neurosci 2016;14: 231-7.
67. Jayasinghe TN, Chiavaroli V, Holland DJ, Cutfield WS, O'Sullivan JM. The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation. Front Cell Infect Microbiol 2016;6: 15.
68. Marotz CA, Zarrinpar A. Treating Obesity and Metabolic Syndrome with Fecal Microbiota Transplantation. Yale J Biol Med 2016;89: 383-8.
69. Cani PD, Delzenne NM. Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care 2007;10: 729-34.
70. Vrieze A, Van Nood E, Holleman F, Salojarvi J, Kootte RS, Bartelsman JF, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012;143: 913-6.e7.
71. Bilinski J, Grzesiowski P, Muszynski J, Wroblewska M, Madry K, Robak K, et al. Fecal Microbiota Transplantation Inhibits Multidrug-Resistant Gut Pathogens: Preliminary Report Performed in an Immunocompromised Host. Arch Immunol Ther Exp (Warsz) 2016;64: 255-8.
72. Borody Tj NA, Finlayson S. The GI microbiome and its role in chronic fatigue syndrome: A summary of bacteriotherapy. J Australas Coll Nutr Env Med 2012;31: 3-8.
73. Sohn KM, Cheon S, Kim YS. Can Fecal Microbiota Transplantation (FMT) Eradicate Fecal Colonization With Vancomycin-Resistant Enterococci (VRE)? Infect Control Hosp Epidemiol 2016;37: 1519-21.
74. Wei Y, Yang J, Wang J, Yang Y, Huang J, Gong H, et al. Successful treatment with fecal microbiota transplantation in patients with multiple organ dysfunction syndrome and diarrhea following severe sepsis. Crit Care 2016;20: 332.
75. Kakihana K, Fujioka Y, Suda W, Najima Y, Kuwata G, Sasajima S, et al. Fecal microbiota transplantation for patients with steroid-resistant/dependent acute graft-versushost disease of the gut. Blood 2016;128: 2083-8.
76. Cammarota G, Pecere S, Ianiro G, Masucci L, Curro D. Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases. Dig Dis 2016;34: 279-85.
77. Li M, Liang P, Li Z, Wang Y, Zhang G, Gao H, et al. Fecal microbiota transplantation and bacterial consortium transplantation have comparable effects on the reestablishment of mucosal barrier function in mice with intestinal dysbiosis. Front Microbiol 2015;6: 692.
78. Petrof EO, Gloor GB, Vanner SJ, Weese SJ, Carter D, Daigneault MC, et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'Re-POOPulating' the gut. Microbiome 2013;1: 3.
79. Allen-Vercoe E, Petrof EO. Artificial stool transplantation: Progress towards a safer, more effective and acceptable alternative. Expert Rev Gastroenterol Hepatol 2013;7: 291-3.